Uptake and bioconversion of stereoisomeric dipeptide prodrugs of ganciclovir by nanoparticulate carriers in corneal epithelial cells

Drug Delivery
Xiaoyan YangAshim K Mitra

Abstract

The objective of this study is to investigate cellular uptake of prodrug-loaded nanoparticle (NP). Another objective is to study bioconversion of stereoisomeric dipeptide prodrugs of ganciclovir (GCV) including L-Val-L-Val-GCV (LLGCV), L-Val-D-Val-GCV (LDGCV) and d-Val-l-Val-GCV (DLGCV) in human corneal epithelial cell (HCEC) model. Poly(D,L-lactic-co-glycolic acid) (PLGA) NP encapsulating prodrugs of GCV were formulated under a double emulsion method. Fluorescein isothiocyanate isomer-PLGA conjugates were synthesized to fabricate biocompatible fluorescent PLGA NP. Intracellular uptake of FITC-labeled NP was visualized by a fluorescent microscope in HCEC cells. Fluorescent PLGA NP and non-fluorescent NP display similar hydrodynamic diameter in the range of 115-145 nm with a narrow particle size distribution and zeta potentials around -13 mV. Both NP types showed identical intracellular accumulation in HCEC cells. Maximum uptake (around 60%) was noted at 3 h for NP. Cellular uptake and intracellular accumulation of prodrugs are significantly different among three stereoisomeric dipeptide prodrugs. The microscopic images show that NPs are avidly internalized by HCEC cells and distributed throughout the cytoplasm instead of being ...Continue Reading

References

Jan 1, 1991·Current Eye Research·J L TaylorW J O'Brien
May 23, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Sreeraj Macha, Ashim K Mitra
Jan 23, 2003·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Giridhar S TirucheraiAshim K Mitra
Oct 26, 2005·International Journal of Pharmaceutics·Kunal PatelAshim K Mitra
Jan 3, 2006·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Soumyajit MajumdarAshim K Mitra
Jun 13, 2006·Antiviral Research·Karen K Biron
Aug 24, 2006·JAMA : the Journal of the American Medical Association·Fujie XuLauri E Markowitz
Jan 24, 2007·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Sriram GundaAshim K Mitra
Sep 7, 2007·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Viral KansaraAshim K Mitra
Jun 25, 2008·International Journal of Pharmaceutics·Ravi S TalluriAshim K Mitra
Mar 12, 2009·Infectious Disorders Drug Targets·Geneviève BillaudFlorence Morfin
Feb 20, 2010·Interdisciplinary Perspectives on Infectious Diseases·Guey-Chuen Perng, Clinton Jones
Apr 20, 2011·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Jwala JwalaAshim K Mitra
Apr 1, 2014·Advances in Experimental Medicine and Biology·Isaac M AdjeiVinod Labhasetwar
Jul 2, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Basit YameenOmid C Farokhzad

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.